Board of Directors
Michael Graves, Chairman
Michael Graves was President and Chief Executive Office of Paddock Laboratories, a developer, manufacturer and marketer of OTC and specialty brand and generic prescription products from 2007 to July 2011. Mr. Graves grew the sales of the company from $65 million to over $220 million prior to its acquisition by Perrigo for $540 million dollars. Prior to his position with Paddock Laboratories Mr. Graves was President of the Generic Division of Par Pharmaceutical, at which time, was the fifth largest marketer of generic products in the United States. Mr. Graves has also held executive positions at two of the country’s largest pharmaceutical distributors. Mr. Graves received a BS from the State University of New York, Buffalo and has over 18 years of diverse pharmaceutical experience.
Karen Arnold co-founded Nanocopoeia after serving as founder and CEO of Education Platform Group (SchoolExtra). With an extensive track record of growing technology businesses and moving products and technologies into commercial scale operations, Ms. Arnold is a expert in turn-around consulting, business development, corporate partnering, technology commercialization, corporate finance, strategy planning and implementation, operations development and start-up, research and engineering. Ms. Arnold has worked with technology businesses in industries as diverse as medical devices, biotechnology, information technology and industrial manufacturing. She holds a B.S. in electrical engineering and master's degrees in business administration and manufacturing operations.
Bonnie Baskin, Ph.D.
Bonnie Baskin, Ph.D., is the founder and past CEO of Viromed Laboratories, a nationally recognized clinical infectious disease testing laboratory and AppTec, an international provider of regulatory-compliant testing and cGMP manufacturing services for biopharmaceuticals and medical devices. She founded her first company – Viromed Laboratories – in the early 1980s and built it from a small independent virology laboratory into a nationally recognized leader in clinical infectious diseases and industrial biosafety testing. After steering the acquisition of the clinical infectious diseases division of that business by Laboratory Corporation of America in 2001, she reorganized the remaining biotech/medical device service components as the newly formed AppTec and secured venture capital to further grow the company. This allowed for the successful expansion of AppTec's services into biopharmaceutical manufacturing and in 2008 sold AppTec to WuXi Pharmatech. Baskin serves on a number of private and non-profit boards and is a past president of MNBIO, the Minnesota Biotech Association.
K. James Ehlen, M.D.
Dr. K. James Ehlen: Dr. Ehlen is currently the Chief Executive Officer of RespirTech a medical device manufacturer based in Minnesota. Dr. Ehlen is a seasoned business executive with extensive experience in clinical medicine, managed healthcare, healthcare system management and the medical device industry.
Before RespirTech, Dr. Ehlen served as Chief Executive Officer of Epien Medical. Prior to that, he served as chairman for Halleland Health Consulting - a leading Minneapolis-based consulting group with expertise in regulatory and compliance affairs, clinical and health system integration, strategy and product positioning and matters of corporate accountability including governance, ethics, and healthcare policy.
Ehlen earned his medical degree at the University of Minnesota and subsequently became board certified in endocrinology. After service in the United States Army as Head of the Endocrinology Section at Brooke Army Medical Center, San Antonio, Texas, he devoted several years to private practice before accepting leadership positions in managed care. Mr. Ehlen served as Chairman and CEO of Medica and Physicians Health Plan of Minnesota and was the founder and co-CEO of Allina Health System. Later, as Chief of Clinical Leadership at Humana, he was responsible for redesigning and restructuring clinical services at all levels throughout the six million member national managed care organization. He has served as a clinical professor of Internal Medicine at the University of Minnesota.
David Frauenshuh has more than 40 years of experience in commercial real estate. With his extensive management and marketing expertise, he has built a reputation for himself as well as for Frauenshuh, Inc. Today, he has ownership interest in approximately 4.5 million square feet of real estate. Within the industry, the name Frauenshuh is synonymous with honesty and integrity. Frauenshuh, Inc. has expertise in the area of development and financing of Medical Office Buildings, Integrated Ambulatory Centers, Inpatient Hospitals, Outpatient Surgical & Imaging Centers and Full-Service Medical Campuses. Frauenshuh, Inc. also has expertise in headquarters development and acquisition of commercial real estate. Mr. Frauenshuh also has financial interest in several other companies and serves as a real estate advisor to many organizations.
Mr. Frauenshuh serves on the Board of many profit and non-profit organizations, including the following: The Salvation Army National Advisory Board, Chairman of the 2001 Minnesota Prayer Breakfast, Chairman of the Children's House based in Hawaii, and Minnesota Military Family Foundation. He also performs outreach and Christian missionary work with several charitable organizations.
Raj Khankari, PhD., MBA
Raj Khankari is currently Chief Executive Officer of RiboCor, Inc. Prior to RiboCor, Dr. Khankari was the General Manager and Vice-President of Worldwide Drug Technologies for CIMA LABS INC., a Cephalon company, where he was responsible for the performance and growth of the drug delivery business for Cephalon. The holder of 15 patents and author of several peer-reviewed journal articles, Dr. Khankari has more than 16 years of experience in developing and successfully introducing pharmaceutical products to the market. That experience includes numerous technology licensing transactions, domestic and international. While at RiboCor, Dr. Khankari successfully licensed the Corvalen product and divested the bulk ingredient Ribose business. Dr. Khankari holds Ph.D. (Pharmaceutics) and MBA degrees from the University of Minnesota, an MS degree (Physical Pharmacy) from the University of Cincinnati, and an M.Pharm and a B.Pharm from India.
John C. Penn was Chairman and Chief Executive Officer of Intek Plastics, Inc., a privately owned plastic extruder located in Hastings, Minnesota. He served as Chairman since 1988 and as CEO intermittently since 2003. Mr. Penn also served as Vice Chairman and Chief Executive Officer of the Satellite Companies from 1998 to March 2003. From 1990 to 1997, Mr. Penn was the President and Chief Executive Officer of Centers for Diagnostic Imaging. Previously, he served in a senior management capacity in various manufacturing companies. John brings to the Nanocopoeia board extensive experience in governing companies in a variety of industries ranging from medical services and equipment to plastics and metal manufacturing. He also served as a C-suite officer for more than 30 years in these same industries. His experience on more than 25 boards of public and private companies also includes extensive experience in the non-profit sector for senior citizens.
Mary Pawlenty, Esq.
Mary Pawlenty is a mediator and arbitrator of civil disputes with Gilbert Mediation. From October 1994 until February 2007, she was a Minnesota District Court Judge in the First Judicial District. The First Judicial District includes the seven counties of Dakota, Carver, Goodhue, Scott, Le Sueur, McLeod and Sibley. Prior to becoming a judge, she was a partner with the law firm of Rider, Bennett, Egan and Arundel. She began her legal career in Houston, Texas at the law firm of Vinson & Elkins. Her work as a civil litigator included a wide variety of civil cases including personal injury matters, employment litigation, insurance coverage, product liability cases and contract disputes. She received her bachelor's degree, summa cum laude, from Bethel University in 1983, and her juris doctor, cum laude, from the University of Minnesota Law School in 1986.